arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BeyondSpring Inc.

BYSI
$0.88 ▼ -0.01 (-0.97%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
12 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

BeyondSpring Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin
ROIC 28.1%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-1.01M
↑ +91.0%
FCF / Share Free cash flow per share
$-0.70
↑ +45.2%
Long-Term Debt Long-term obligations
$2.17M
↑ +50.9%

Health Breakdown

Returns
50
Cash Quality
99

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 19 quarters